These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 38112999)

  • 1. Recent Advances of RNA m
    Ma S; Barr T; Yu J
    Cancer Treat Res; 2023; 190():49-94. PubMed ID: 38112999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer immunoediting and resistance to T cell-based immunotherapy.
    O'Donnell JS; Teng MWL; Smyth MJ
    Nat Rev Clin Oncol; 2019 Mar; 16(3):151-167. PubMed ID: 30523282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting RNA N
    Li W; Hao Y; Zhang X; Xu S; Pang D
    Mol Cancer; 2022 Sep; 21(1):176. PubMed ID: 36071523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA N
    Zhang Z; Zhang C; Luo Y; Zhang G; Wu P; Sun N; He J
    Clin Transl Med; 2021 Sep; 11(9):e525. PubMed ID: 34586737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel strategies for cancer immunotherapy: counter-immunoediting therapy.
    Liu S; Sun Q; Ren X
    J Hematol Oncol; 2023 Apr; 16(1):38. PubMed ID: 37055849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles and therapeutic implications of m6A modification in cancer immunotherapy.
    Pan J; Huang T; Deng Z; Zou C
    Front Immunol; 2023; 14():1132601. PubMed ID: 36960074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the RNA m
    Li X; Ma S; Deng Y; Yi P; Yu J
    Mol Cancer; 2022 Mar; 21(1):76. PubMed ID: 35296338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cancer Immunoediting in the Development of Cancer Immunotherapy].
    Ariyasu R; Nishikawa H
    Gan To Kagaku Ryoho; 2019 Mar; 46(3):407-411. PubMed ID: 30914573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Immunoediting in the Era of Immuno-oncology.
    Gubin MM; Vesely MD
    Clin Cancer Res; 2022 Sep; 28(18):3917-3928. PubMed ID: 35594163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in RNA m
    Verghese M; Wilkinson E; He YY
    Cancer Treat Res; 2023; 190():95-142. PubMed ID: 38113000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosurveillance and Immunoediting of Lung Cancer: Current Perspectives and Challenges.
    Kunimasa K; Goto T
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surmounting cancer drug resistance: New insights from the perspective of N
    Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
    Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting RNA N6-methyladenosine to synergize with immune checkpoint therapy.
    Zhou X; Li C; Chen T; Li W; Wang X; Yang Q
    Mol Cancer; 2023 Feb; 22(1):36. PubMed ID: 36810108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA modifications in cancer immune therapy: regulators of immune cells and immune checkpoints.
    Qin X; Liu H; Zhang Q; Che Y; Lei T; Tang F; Hu Q
    Front Immunol; 2024; 15():1463847. PubMed ID: 39372415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From Cancer Immunoediting to New Strategies in Cancer Immunotherapy: The Roles of Immune Cells and Mechanics in Oncology.
    Aragon-Sanabria V; Kim GB; Dong C
    Adv Exp Med Biol; 2018; 1092():113-138. PubMed ID: 30368751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Have Cells Harboring the HIV Reservoir Been Immunoedited?
    Huang SH; McCann CD; Mota TM; Wang C; Lipkin SM; Jones RB
    Front Immunol; 2019; 10():1842. PubMed ID: 31447850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic reprogramming of T cells: unlocking new avenues for cancer immunotherapy.
    Singh V; Nandi S; Ghosh A; Adhikary S; Mukherjee S; Roy S; Das C
    Cancer Metastasis Rev; 2024 Mar; 43(1):175-195. PubMed ID: 38233727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Immunoediting: Elimination, Equilibrium, and Immune Escape in Solid Tumors.
    Wilczyński JR; Nowak M
    Exp Suppl; 2022; 113():1-57. PubMed ID: 35165859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy.
    Guo L; Yang H; Zhou C; Shi Y; Huang L; Zhang J
    Front Immunol; 2021; 12():773570. PubMed ID: 34956201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic applications of the cancer immunoediting hypothesis.
    Desai R; Coxon AT; Dunn GP
    Semin Cancer Biol; 2022 Jan; 78():63-77. PubMed ID: 33711414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.